Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, June 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 193 articles: HTML format

Single Articles

1. ZHENG K, Zheng X, Li J, Xu M, et al
   Single-cell transcriptomics reveals NDRG1/TGF?beta1 associated vascular smooth muscle cell phenotypic switching in chronic thromboembolic pulmonary hypertension.
   J Thromb Thrombolysis. 2026 May 29. doi: 10.1007/s11239-026-03288.
   PubMed    
   Abstract available
   
   

2. MCCARTHY BE, Feng R, Bernardo R, Shlobin OA, et al
   Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
   Ann Am Thorac Soc. 2026 May 29:aaoag141. doi: 10.1093.
   PubMed    
   Abstract available
   
   

3. SCABELLO RT, de Carvalho-Pinto RM, de Parodi LN, de Almeida G, et al
   Prevalence, pathogenesis, and clinical impact of pulmonary hypertension associated with chronic obstructive pulmonary disease.
   Front Cardiovasc Med. 2026;13:1700063.
   PubMed    
   Abstract available
   
   

4. ANDROSHCHUK V, Long E, Sillett C, Chehab O, et al
   Multi-chamber three-dimensional myocardial strain assessment by computed tomography: a comparison with speckle tracking echocardiography and association with pulmonary hypertension in severe aortic stenosis.
   Front Cardiovasc Med. 2026;13:1774091.
   PubMed    
   Abstract available
   
   

5. KRASIC S, Hermuzi A, Dizdarevic I, Topic V, et al
   Case Report: Post-Total anomalous pulmonary venous connection pulmonary hypertension - novel treatment using sirolimus and atrial flow regulator implantation.
   Front Cardiovasc Med. 2026;13:1783773.
   PubMed    
   Abstract available
   
   

6. TARRAS ES, Arun AS, Joseph P, Heerdt PM, et al
   Right Ventricular End-Ejection Pressure Predicts Mortality in Patients With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
   Compr Physiol. 2026;16:e70187.
   PubMed    
   Abstract available
   
   

7. CHEN M, Liao X, Li F, Liu J, et al
   The MCP-1/CCR2-CD16(+) monocyte axis drives thrombus fibrosis in Chronic Thromboembolic Pulmonary Hypertension.
   J Transl Med. 2026 May 28. doi: 10.1186/s12967-026-08283.
   PubMed    
   Abstract available
   
   

8. LUNA-LOPEZ R, Garcia-Alvarez A
   Growing with the patient: toward a lifespan risk score for pediatric pulmonary hypertension.
   Rev Esp Cardiol (Engl Ed). 2026 May 27:S1885-5857(26)00107.
   PubMed    
   
   
   

9. KHURANA JK, Lipsitz S, Geisser DL, Moynihan KM, et al
   Child Opportunity Index Influences Pediatric Pulmonary Hypertension Outcomes: Analyses From the Pediatric Health Information System.
   JACC Adv. 2026;5:102773.
   PubMed    
   Abstract available
   
   

10. YUAN H, Chen B, Gao D, Zhang L, et al
    I-tRF-Asp Promotes Vascular Remodeling in Hypoxic Pulmonary Hypertension Via hnRNPU Phase Separation, Which Affects TCF7L2 Alternative Splicing.
    Arterioscler Thromb Vasc Biol. 2026 May 28. doi: 10.1161/ATVBAHA.126.324681.
    PubMed    
    Abstract available
    
    

11. HE P, Tan W, Zhu Y, Fan J, et al
    Ginsenoside Rg1 attenuates right ventricular remodeling in hypoxic pulmonary hypertension and is associated with suppression of HIF-1alpha-related glycolytic signaling.
    J Basic Clin Physiol Pharmacol. 2026 May 28. doi: 10.1515/jbcpp-2026-0090.
    PubMed    
    Abstract available
    
    

12. ERAKY AM, Mokhtar Y, Grabau G, Khan A, et al
    Calcium Channel Blockers in Critical Care Medicine: Current Clinical Applications and Future Investigational Perspectives.
    Med Sci (Basel). 2026;14:213.
    PubMed    
    Abstract available
    
    

13. ZHOU Q, Zhu G, Zhang P, Qi B, et al
    Construction and Validation of a Predictive Model for Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension Based on Lasso Regression.
    Int J Gen Med. 2026;19:599529.
    PubMed    
    Abstract available
    
    

14. ISHII T, Anzai T, Uchida K, Hosokawa S, et al
    Registry-based estimation of cardiac event-free survival in congenital heart disease complicated by pulmonary hypertension: A nationwide registry study from Japan.
    Int J Cardiol Congenit Heart Dis. 2026;25:100679.
    PubMed    
    Abstract available
    
    

15. AMIRI U, Keceli E, Andersen MO, Mojaddedi S, et al
    Advanced right ventricular evaluation in pulmonary hypertension: the role of 3D echocardiography and strain analysis.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag067.
    PubMed    
    Abstract available
    
    

16. GHANI H, Thillai M, Walsh S, Bussell E, et al
    Anthropometry, sex, and age at diagnosis affect pulmonary blood volume quantification from computed tomography pulmonary angiography in pulmonary hypertension assessment.
    Front Cardiovasc Med. 2026;13:1815977.
    PubMed    
    Abstract available
    
    

17. CHADDA KR, Sathivelu S, Armstrong SK, Edling C, et al
    Rare Models: Use of a Novel Translational Model for Diffuse Alveolar Haemorrhage.
    Int J Mol Sci. 2026;27:4157.
    PubMed    
    Abstract available
    
    

18. CONDE-CAMACHO R, Tuta-Quintero E, Mora-Barrero A, Bastidas-Goyes A, et al
    Hemodynamic and Thrombotic Vulnerability in Pulmonary Arterial Hypertension at High Altitude: Multivariable Predictors of Mortality.
    Medicina (Kaunas). 2026;62:996.
    PubMed    
    Abstract available
    
    

19. SUN Y, Zhang Q, Huang Y, Liu X, et al
    A Rare Case of Multi-System Involvement and Hereditary Pulmonary Hypertension Caused by De Novo Heterozygous CAV1 Mutation in a Pediatric Patient.
    Children (Basel). 2026;13:694.
    PubMed    
    Abstract available
    
    

20. VYAS-READ S, Bhombal S, Siddaiah R, Cua CL, et al
    Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD Collaborative.
    Children (Basel). 2026;13:646.
    PubMed    
    Abstract available
    
    

21. SILVA VBC, Lucina SB, Wolf M, Sarraff AP, et al
    Right ventricular systolic function in dogs with pulmonary hypertension can be assessed using tissue motion annular displacement.
    Am J Vet Res. 2026 May 26:1-8. doi: 10.2460/ajvr.26.03.0107.
    PubMed    
    Abstract available
    
    

22. CHEN Z, Pang L, Zheng Y, Xu L, et al
    Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension.
    J Cardiovasc Dev Dis. 2026;13:195.
    PubMed    
    Abstract available
    
    

23. RAMAZANI N, Barnes L, Wong A, Sharma D, et al
    The New Era of Pulmonary Hypertension: The Dawn of Disease Modification & Therapeutic Modalities.
    J Cardiovasc Dev Dis. 2026;13:174.
    PubMed    
    Abstract available
    
    

24. LIU Z, Liu X, Mprah R, Sun H, et al
    Sodium Selenite Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension by Upregulating GPX3 and Ameliorating Vascular Remodeling.
    Physiol Res. 2026;75:325-335.
    PubMed    
    Abstract available
    
    

25. WANG D, Li Y, Wang H, Zhang J, et al
    Shortened Pulmonary Pulse Wave Transit Time in High-Altitude Residents Without Pulmonary Hypertension: An Doppler Echocardiography Study.
    Physiol Res. 2026;75:315-323.
    PubMed    
    Abstract available
    
    

26. WANG D, Fang Y, Wu X, Zhang J, et al
    Increased Right Ventricular Cardiac Output to Left Ventricular Cardiac Output Ratio in High-Altitude Residents Without Pulmonary Hypertension: An Echocardiography Study.
    Physiol Res. 2026;75:257-264.
    PubMed    
    Abstract available
    
    

27. TRINDADE P, Dias A, Santos FP, Froes F, et al
    Management of acute respiratory failure in pulmonary hypertension in the ICU: Ten years of experience.
    Pulmonology. 2026;32:2679340.
    PubMed    
    
    
    

28. TERAMACHI R, Fukihara J, Ichihara S, Kataoka K, et al
    Early risk response to vasodilators and outcomes in interstitial lung disease associated pulmonary hypertension.
    Respir Investig. 2026;64:101453.
    PubMed    
    Abstract available
    
    

29. BULARD BA, Kumpfbeck AR, Woo Y, Simonds E, et al
    Structured Exercise Regimen in Pulmonary Hypertension-Right Ventricular Failure in an Ovine Model.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

30. WHITE YN, Douglass M, Van Boerum J, Rebentisch A, et al
    Cardiac Catheterization for Assessment of Pulmonary Hypertension in Preterm Lambs.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

31. CUSTODIO JM, Rodgers N, Aggarwal V
    Digital Subtraction Pulmonary Angiography: A Useful Tool to Evaluate Pediatric Pulmonary Hypertension.
    Pediatr Cardiol. 2026 May 25. doi: 10.1007/s00246-026-04311.
    PubMed    
    Abstract available
    
    

32. YOO HHB, Rroku A, Thevathasan T
    Editorial: Pulmonary embolism and pulmonary hypertension: from acute management to long-term phenotyping.
    Front Cardiovasc Med. 2026;13:1851852.
    PubMed    
    
    
    

33. GILBOA-SAGY H, Romem A, Guber E, Epstein Shochet G, et al
    Transbronchial cryobiopsy is safe for patients with echocardiographic evidence of pulmonary hypertension: a blinded prospective cohort study.
    Front Med (Lausanne). 2026;13:1842852.
    PubMed    
    Abstract available
    
    

34. VANDERWILDE AJ, Miles KG, Becker KC, Critser PJ, et al
    Oxygen Consumption and Oxygen Pulse Patterns in Two Pediatric Patients With Pulmonary Hypertension and Different Clinical Responses: A Case Report.
    Case Rep Pediatr. 2026;2026:6697634.
    PubMed    
    Abstract available
    
    

35. PAVULURI SK, Zahn E, Sather J, Finocchio T, et al
    Eliminating a Latent Safety Threat in Emergency Care: A High-Reliability, Automated Strategy for Prostacyclin Continuity in Pulmonary Hypertension Patients.
    J Patient Saf. 2026 May 22. doi: 10.1097/PTS.0000000000001499.
    PubMed    
    
    
    

36. LANTOS L, Somogyvari Z, Szell A, Belteki G, et al
    [Use of inhaled nitric oxide during neonatal transport - a review of seven years of experience].
    Orv Hetil. 2026;167:824-832.
    PubMed    
    Abstract available
    
    

37. LI X, Li H, Feng B, Chen X, et al
    Expression of concern to "Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition" [Biomed. Pharmacother. 177 (2024) 117023].
    Biomed Pharmacother. 2026;199:119313.
    PubMed    
    
    
    

38. DIENER J, Soni H, Booe J, Darce J, et al
    Development of a long-acting relaxin for the treatment of pulmonary hypertension.
    Br J Pharmacol. 2026 May 22. doi: 10.1111/bph.70498.
    PubMed    
    Abstract available
    
    

39. LU H, Zhang M, Gong S, Liang N, et al
    The CCL2 network in pulmonary hypertension: Potential therapeutic targets.
    Cell Signal. 2026;145:112606.
    PubMed    
    Abstract available
    
    

40. ZHOU WY, Wu XL, Wang SY, Zhang XY, et al
    TBX5-GATA4 interaction aggravates pulmonary artery smooth muscle proliferation and pathogenesis of pulmonary arterial hypertension through transcriptional co-activating CDK18.
    Life Sci. 2026;398:124453.
    PubMed    
    Abstract available
    
    

41. ZHAO J, Shi G, Han H, Zeng M, et al
    Dual-Scale Liposomal Assembly Enables Alveolar Macrophage-Targeted Gene Delivery in High-Altitude Pulmonary Edema and Acute Lung Injury.
    ACS Nano. 2026;20:14458-14478.
    PubMed    
    Abstract available
    
    

42. LI M, Wang Y, Liang X, Zhao C, et al
    Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular Remodeling.
    J Med Chem. 2026;69:12205-12222.
    PubMed    
    Abstract available
    
    

43. LUO Q, Li S, Huang Z, Ran Y, et al
    Prognostic value of TAPSE/sPAP in pulmonary arterial hypertension: a systematic review and meta-analysis.
    Respir Med. 2026;258:108861.
    PubMed    
    Abstract available
    
    

44. SALIBE-FILHO W, Zorze Rossetto N, Tatagiba LS, de Deus MontAlverne Parente Y, et al
    Evaluating sotatercept in the treatment of pulmonary arterial hypertension.
    Future Cardiol. 2026;22:463-472.
    PubMed    
    Abstract available
    
    

45. HUANG S, Chen Z, Gong W, Song Y, et al
    Kisspeptin-10 attenuates pulmonary arterial hypertension via restoration of mitochondrial function in pulmonary artery smooth muscle cells.
    Neuropeptides. 2026;117:102611.
    PubMed    
    Abstract available
    
    

46. QIU L, Lu T, Zhang J, Liu M, et al
    Targeting REV-ERBalpha/BNIP3 axis attenuates pulmonary arterial hypertension by repressing mitophagy in mice.
    Nat Commun. 2026;17:4793.
    PubMed    
    Abstract available
    
    

47. HUANG W, Wang X, Wu W, Wang Y, et al
    SMAD7 Downregulation Promotes Ferroptosis in Pulmonary Arterial Hypertension Via the TGF-beta1-SMAD2/3 Pathway.
    Shock. 2026;65:1021-1036.
    PubMed    
    Abstract available
    
    

48. SI S, Wang H, Xu Y, Wang J, et al
    Scalable Production of Multi-Source Hybrid Biomimetic Exosomes Co-Loaded with Therapeutic Plasmids for Treatment of High-Altitude Pulmonary Edema.
    Adv Healthc Mater. 2026;15:e04014.
    PubMed    
    Abstract available
    
    

49. BERGER RMF, Dunbar Ivy D, Borissoff JI, Cerovic S, et al
    Macitentan in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial.
    J Pediatr. 2026;293:115057.
    PubMed    
    Abstract available
    
    

50. TAZIBT D, Vacelet V, Vendeville S, Seronde MF, et al
    Coexistence of hepatopulmonary syndrome and portopulmonary hypertension before a liver transplantation: a case report and review of the literature.
    Eur J Gastroenterol Hepatol. 2026;38:874-878.
    PubMed    
    Abstract available
    
    

51. WREN JT JR, Hyland RM, McNamara PJ
    Initial Hemodynamic Phenotypes and Clinical Trajectory in Congenital Diaphragmatic Hernia: A Pilot Study.
    J Pediatr. 2026 Feb 19:115044. doi: 10.1016/j.jpeds.2026.115044.
    PubMed    
    Abstract available
    
    

52. IWAHORI T, Hayashi Y, Tsuchiya H, Hirata T, et al
    Regional Disparities in Access to Specialized Facilities and Prescription Preference for Initial Pulmonary Arterial Hypertension Treatment?- A Nationwide Study Using the National Database of Health Insurance Claims.
    Circ J. 2026;90:736-738.
    PubMed    
    Abstract available
    
    

53. LIU HY, Cheng MC, Chien SJ, Lin YJ, et al
    The impact and outcome of the presence of ductus arteriosus in neonatal peripheral extracorporeal membrane oxygenation.
    Pediatr Neonatol. 2026;67:288-292.
    PubMed    
    Abstract available
    
    

54. NAKAMURA T, Tahara N, Koga Y, Yamagata Y, et al
    Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study.
    J Nucl Cardiol. 2026 Jun 3:102770. doi: 10.1016/j.nuclcard.2026.102770.
    PubMed    
    Abstract available
    
    

55. LI M, Zhang Y, Liu M, Lv C, et al
    A young woman with dramatic pulmonary hypertension and respiratory failure: a case report.
    Front Med (Lausanne). 2026;13:1788480.
    PubMed    
    Abstract available
    
    

56. 
    Erratum: Chinese Herbal Medicine in Hypoxic Pulmonary Hypertension Treatment: Mechanisms, Progress, and Future Directions [Corrigendum].
    Drug Des Devel Ther. 2026;20:570449.
    PubMed    
    Abstract available
    
    

57. BAJOUKA J, Matti C, Touza G, Patel K, et al
    Multifactorial Pulmonary Hypertension: Converging Roles of Sarcoidosis, Heart Failure With Reduced Ejection Fraction, and Chronic Thromboembolic Disease.
    Cureus. 2026;18:e108187.
    PubMed    
    Abstract available
    
    

58. XIANG XJ, Ma DY, Liu MY, Ma L, et al
    Association between a composite metabolic index and mortality in critically ill patients with pulmonary hypertension: a retrospective cohort study.
    Sci Rep. 2026 Jun 3. doi: 10.1038/s41598-026-56432.
    PubMed    
    Abstract available
    
    

59. JIANG WD, Xu MY, Chen ZY, Chen Q, et al
    Loss of Brg1 prevents the progression of pulmonary hypertension by inhibiting Nrf2 expression.
    Sci Rep. 2026 Jun 3. doi: 10.1038/s41598-026-55301.
    PubMed    
    Abstract available
    
    

60. XU XR, Chen L, Sun KY, Qin XB, et al
    Dissociation of UPR signaling and ER ultrastructure during 4-PBA therapy in shunt-driven pulmonary hypertension.
    Am J Hypertens. 2026 Jun 3:hpag052. doi: 10.1093.
    PubMed    
    Abstract available
    
    

61. SUN ZY, Zhao XX, Pan-Han, Li J, et al
    Assessment of Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Echocardiography. 2026;43:e70444.
    PubMed    
    Abstract available
    
    

62. BASKIN SM, Pulton DA, Vasant D, Salamanca-Padilla YY, et al
    Early predictors and outcomes of mechanical circulatory support use during single lung transplant for secondary pulmonary hypertension: A large single-center experience.
    JHLT Open. 2026;13:100587.
    PubMed    
    Abstract available
    
    

63. DONG Y, Lu C, Luo T, Zeng J, et al
    Isolated Absence of the Right Pulmonary Artery: A Rare Cause of Pulmonary Hypertension in Adults.
    Eur Heart J Cardiovasc Imaging. 2026 Jun 2:jeag136. doi: 10.1093.
    PubMed    
    
    
    

64. FAVRIN G, Cappello E, Rattotti S, Picone C, et al
    Regression of T-LGL leukemia in a patient treated with sildenafil for pulmonary hypertension.
    Leuk Res. 2026;167:108257.
    PubMed    
    
    
    

65. WANG X, Wang Y, Wang H, Zeng Z, et al
    Leveraging Untargeted Metabolomics and Molecular Dynamics Simulation Unraveling the Multi-Target Mechanism of Taohong Siwu Decoction against Pulmonary Hypertension.
    Curr Pharm Des. 2026 May 25. doi: 10.2174/0113816128446449260213204759.
    PubMed    
    Abstract available
    
    

66. CASTIGLIONE A, Bergstrom E, Kjellstrom B, Radegran G, et al
    CMR-derived left ventricular pressure-volume loops enhance individualized assessment of disease severity and prognosis in pulmonary arterial hypertension in adults.
    Physiol Rep. 2026;14:e70935.
    PubMed    
    Abstract available
    
    

67. ISHIMARU S, Mizuno S, Tanada T, Saito D, et al
    [Pulmonary Arterial Hypertension Impairs Duodenal Barrier Integrity in Rats].
    Yakugaku Zasshi. 2026;146:603-610.
    PubMed    
    Abstract available
    
    

68. VALENTIN S, Odille F, Sorel D, Baptista BR, et al
    Multimodal evaluation in pulmonary hypertension: Contextualizing native T1 mapping.
    Respir Med Res. 2026;89:101279.
    PubMed    
    
    
    

69. MATHAVAN A, Mathavan A, Krekora U, Rojas ORG, et al
    BMPR2 Splice-Site Variant in a Patient With Pulmonary Arteriovenous Malformation and Delayed-Onset Pulmonary Arterial Hypertension: A Case Report and Mechanistic Phenocopy Hypothesis.
    Am J Med Genet A. 2026;200:1682-1690.
    PubMed    
    Abstract available
    
    

70. UYGUR B, Memic Sancar K, Bulut U, Kahraman S, et al
    Role of the coronary sinus in risk stratification and prognostic evaluation of idiopathic pulmonary arterial hypertension.
    Herz. 2026;51:222-229.
    PubMed    
    Abstract available
    
    

71. FARINA JM, Scalia IG, Pietri MP, Abbas MT, et al
    Evaluation of ePLAR, the echocardiographic pulmonary to left atrial ratio, in a large cohort with pulmonary hypertension.
    Eur Heart J Open. 2025;6:oeaf174.
    PubMed    
    Abstract available
    
    

72. TAMILSELVAN K, Arumugam A, Vadivelu M, Senthilkumar K, et al
    Prevalence and Associated Echocardiographic Findings of Pulmonary Hypertension in Chronic Kidney Disease: A Cross-Sectional Study.
    Cureus. 2026;18:e108609.
    PubMed    
    Abstract available
    
    

73. LARPNARONGCHAI S, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Clinical Factors Associated with Ventilator-Free Days in Newborns with Persistent Pulmonary Hypertension of the Newborn: A Retrospective Cohort Study in Thailand.
    J Clin Med. 2026;15:4377.
    PubMed    
    Abstract available
    
    

74. ROSTAGNO C, Cartei A, Rubbieri G, Ceccofiglio A, et al
    Echocardiography Does Not Delay Surgery in Elderly Patients with Hip Fractures, and Pulmonary Hypertension and Decreased Left Ventricular Ejection Fraction Are Associated with In-Hospital Mortality.
    J Clin Med. 2026;15:4284.
    PubMed    
    Abstract available
    
    

75. CHEN X, Su J, Liu H, Qin Y, et al
    Endothelial-to-Mesenchymal Transition Mechanisms in Vascular Remodeling of Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:4951.
    PubMed    
    Abstract available
    
    

76. MOOERS EA, Lakshminrusimha S, Konduri GG
    Advances in the Management of Persistent Pulmonary Hypertension of the Newborn.
    Clin Perinatol. 2026;53:297-316.
    PubMed    
    Abstract available
    
    

77. HINOJOSA W, Rodriguez-Munoz D, Lopez-Alacid I, Ynsaurriaga FA, et al
    Atrial flutter ablation in pulmonary hypertension: a national referral center experience.
    Rev Esp Cardiol (Engl Ed). 2026 Jun 11:S1885-5857(26)00127.
    PubMed    
    
    
    

78. ROBERTSON L, Bunclark K, Toshner M, Pepke-Zaba J, et al
    Diurnal and seasonal variation in six-minute walk distance in pulmonary hypertension: Implications for clinical monitoring.
    Chron Respir Dis. 2026;23:14799731261460039.
    PubMed    
    Abstract available
    
    

79. KISHIGAMI D, Shimokawahara H, Takahashi K, Kobashi S, et al
    Three-Color SUV(LV)-Normalized SPECT/CT to Visualize Dynamic Pulmonary Perfusion in Chronic Thromboembolic Pulmonary Hypertension.
    Circ Rep. 2026;8:1011-1012.
    PubMed    
    Abstract available
    
    

80. KASAHARA T, Yamashita J, Komatsu I, Shimahara Y, et al
    Combined therapeutic strategy of balloon pulmonary angioplasty before and after pulmonary endarterectomy in a patient with severe chronic thromboembolic pulmonary hypertension with Kartagener's syndrome: a case report.
    Eur Heart J Case Rep. 2025;10:ytaf349.
    PubMed    
    Abstract available
    
    

81. RYSZKIEWICZ P, Remiszewski P, Pedzinska-Betiuk A, Minczuk K, et al
    Chronic simultaneous inducible nitric oxide synthase (iNOS) and peripheral cannabinoid CB(1) receptors blockade ameliorates pulmonary hypertension in monocrotaline-induced rat model.
    Front Pharmacol. 2026;17:1831802.
    PubMed    
    Abstract available
    
    

82. LESCANO A, Pulido Zamudio T, Conde Camacho R, Caro FM, et al
    Latin American expert opinion paper on the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease.
    Front Med (Lausanne). 2026;13:1798347.
    PubMed    
    Abstract available
    
    

83. NASER JA, Ibrahim HH, Rahme S, Andi K, et al
    Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups.
    JACC Cardiovasc Imaging. 2026 Jun 10:S1936-878X(26)00260.
    PubMed    
    Abstract available
    
    

84. BROSSAT C, Jambon-Barbara C, Hlavaty A, Chaumais MC, et al
    Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.
    ERJ Open Res. 2026;12:01450-2025.
    PubMed    
    Abstract available
    
    

85. PLUNKETT MJ, Sayegh ALC, Lewis RA, McWilliams TJ, et al
    Slow deep breathing reduces muscle sympathetic nerve activity and improves breathing efficiency in pulmonary hypertension.
    ERJ Open Res. 2026;12:01329-2025.
    PubMed    
    Abstract available
    
    

86. ZHANG JJ, Huang YQ, Liu XK, Sun XL, et al
    Research advances in chronic thromboembolic pulmonary hypertension: from pathological mechanisms to multidisciplinary management.
    Front Cardiovasc Med. 2026;13:1832792.
    PubMed    
    Abstract available
    
    

87. CUSMAI C, Gulati S, Laskey D, Sun T, et al
    Successful Single Lung Transplantation in Severe Group III Pulmonary Hypertension.
    Ann Thorac Surg Short Rep. 2025;4:423-427.
    PubMed    
    Abstract available
    
    

88. AHANGAR H, Ghasemi Palangi M, Gohari S, Yasami P, et al
    A Case of Chronic Thromboembolic Pulmonary Hypertension and Pregnancy, Managed With Pulmonary Endarterectomy: Clinical Challenges, Case Report, and Literature Review.
    Clin Case Rep. 2026;14:e72864.
    PubMed    
    Abstract available
    
    

89. GONG D, Liu R, Deng X, Xing J, et al
    Licochalcone B alleviates pulmonary vascular remodeling via inhibiting Furin/TGF-beta1 in pulmonary hypertension.
    Phytomedicine. 2026;158:158373.
    PubMed    
    Abstract available
    
    

90. DING QS, Li M, Wang YH, Li L, et al
    Echocardiographic evaluation of right ventricular function before and after percutaneous coronary intervention in patients with coronary artery disease and pulmonary hypertension: A single-center retrospective cohort study.
    Medicine (Baltimore). 2026;105:e49028.
    PubMed    
    Abstract available
    
    

91. LI OM, Ghani H, Appenzeller P, Amaral-Almeida L, et al
    Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry.
    Open Heart. 2026;13:e004169.
    PubMed    
    Abstract available
    
    

92. BAUER M, Santhanam L, Steppan J
    Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

93. DEVALLA L, Wagh PB, Ghewade B
    A rare etiology of pulmonary hypertension: The scimitar syndrome.
    J Family Med Prim Care. 2026;15:1445-1447.
    PubMed    
    Abstract available
    
    

94. NILSSON CN, Aljohani OA, Smith MA, Durand R, et al
    Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report.
    Clin Case Rep. 2026;14:e72831.
    PubMed    
    Abstract available
    
    

95. ABDUL KHALEK J, Al Hajjar M, Al-Khalil Z, Salem J, et al
    Unveiling the Link Between COVID-19 and Pulmonary Hypertension.
    Can J Infect Dis Med Microbiol. 2026;2026:9352258.
    PubMed    
    Abstract available
    
    

96. FUJII H, Isobe S, Taniguchi Y, Tamura Y, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in an Adolescent With a Novel Frameshift Variant in PROS1.
    Pulm Circ. 2026;16:e70335.
    PubMed    
    Abstract available
    
    

97. POSEY JN, Jordan M, Olsen-Dufour A, Nguyen TN, et al
    Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.
    Front Immunol. 2026;17:1832057.
    PubMed    
    Abstract available
    
    

98. KARIA N, Murphy D, Howard L, Johnson M, et al
    Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UK.
    Echo Res Pract. 2026;13:20.
    PubMed    
    Abstract available
    
    

99. DAOUD A, Goldin G, Goren L, Bagga A, et al
    Echocardiographic characterization of combined postcapillary and precapillary pulmonary hypertension in systemic sclerosis with preserved ejection fraction.
    Echo Res Pract. 2026;13:18.
    PubMed    
    Abstract available
    
    

100. WILD CJB, Coghlan G, Charalampopoulos A, Hameed A, et al
     The impact of right ventricular free wall strain on current international echocardiography guidelines for the assessment of pulmonary hypertension.
     Echo Res Pract. 2026;13:17.
     PubMed    
     Abstract available
     
     

101. HERMANSSON FN, Celestin BE, Bagherzadeh SP, Fahed G, et al
     Impact of guideline definitions on right ventricular diameter in echocardiography: an automated analysis in controls and patients with pulmonary hypertension.
     Echo Res Pract. 2026;13:21.
     PubMed    
     Abstract available
     
     

102. KOHLI A, Mokhlesi B
     Positive Airway Pressure Therapy for Pulmonary Hypertension Associated with Sleep-disordered Breathing.
     Arch Bronconeumol. 2026 May 11:S0300-2896(26)00171.
     PubMed    
     
     
     

103. AWAD A, Hamza M, Rayes A, Al Haly B, et al
     Impact of pulmonary hypertension on long-term clinical outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndrome: Results from a large PCI registry.
     Heart Lung. 2026;79:102841.
     PubMed    
     Abstract available
     
     

104. KUMAR A, Mahajan A, Krishnamachary B, Chen L, et al
     Exposure Pattern Determines Methamphetamine-Induced Right Ventricular Dysfunction and Vascular Remodeling.
     Compr Physiol. 2026;16:e70191.
     PubMed    
     Abstract available
     
     

105. AKTAS I, Yasar E
     Neutrophil Percentage-to-Albumin Ratio as a Novel Biomarker in Patients with Group 1 Pulmonary Arterial Hypertension.
     Niger J Clin Pract. 2026;29:559-566.
     PubMed    
     Abstract available
     
     

106. LIU J, Guo Y, Huang J, Gao Z, et al
     Adipokine Nesfatin-1 Mediates Endothelial Dysfunction by Suppressing MEF2B/BMPR1A During Pulmonary Vascular Remodeling.
     J Am Heart Assoc. 2026;15:e047528.
     PubMed    
     Abstract available
     
     

107. WELLS M, Smith T, Domsic RT, Anilkumar A, et al
     The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.
     Rheumatology (Oxford). 2026;65:keag267.
     PubMed    
     Abstract available
     
     

108. CHEN S, Yin J, Kan Z, Li X, et al
     Angiopoietin-2-mediated integrin alpha5beta1 and FAK signaling contributes to pulmonary arterial hypertension pathogenesis.
     Life Sci. 2026;399:124441.
     PubMed    
     Abstract available
     
     

109. MA Q, You S
     Neutrophil extracellular traps-related biomarkers in idiopathic pulmonary arterial hypertension: A machine learning-based identification and experimental validation study.
     Mol Immunol. 2026;195:25-39.
     PubMed    
     Abstract available
     
     

110. MIRANDA-ALCARAZ L, Mora-Gomez M, Gallego-Zazo N, Cruz-Utrilla A, et al
     Expanding the genetic burden of low-evidence genes in pulmonary arterial hypertension.
     Eur J Hum Genet. 2026;34:831-839.
     PubMed    
     Abstract available
     
     

111. PORRES-AGUILAR M, Johns E, Piazza G, McBane R, et al
     Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.
     Vasc Med. 2026;31:409-420.
     PubMed    
     Abstract available
     
     

112. BOROVIKOVA I, Uporov I, Okhrimenko G, Zamyatin V, et al
     Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension.
     J Struct Biol. 2026;218:108315.
     PubMed    
     Abstract available
     
     

113. MANZI G, Badagliacca R, D'Alto M, Ghio S, et al
     2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.
     Vascul Pharmacol. 2026;163:107590.
     PubMed    
     Abstract available
     
     

114. GHENGHEA R, Pyra P, Dulac Y, Guitarte A, et al
     Myocardial work during various right ventricle load conditions in a paediatric population.
     Arch Cardiovasc Dis. 2026;119.
     PubMed    
     Abstract available
     
     

115. CABADA-GARCIA MJ, Rodriguez-Rivera J, Panneflek J, Andrade-Leal S, et al
     Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.
     Heart Fail Rev. 2026;31:75.
     PubMed    
     Abstract available
     
     

116. WENG S, Ding C, Zhang H, Lai Y, et al
     The bile acid-oxysterol axis in pulmonary arterial hypertension: from sterol trafficking to precision phenotyping and therapeutic opportunities.
     Mol Biol Rep. 2026;53:964.
     PubMed    
     Abstract available
     
     

117. WIRTH C, De Normandie P, Hascoet S, Fadel E, et al
     Learning from a pitfall: Atrial septostomy in LV failure under VA-ECMO for pulmonary hypertension.
     J Extra Corpor Technol. 2026;58:180-183.
     PubMed    
     Abstract available
     
     

118. REDDY YNV, Frantz RP, Egbe AC, Miranda WR, et al
     Phenotypic Characterization of Unclassified Pulmonary Hypertension.
     Circ Heart Fail. 2026 Jun 19:e014480. doi: 10.1161/CIRCHEARTFAILURE.125.014480.
     PubMed    
     Abstract available
     
     

119. LI G, Du X, Luo W, Wei J, et al
     Efficacy and safety of bosentan-related therapy in neonates with persistent pulmonary hypertension of the newborn: a systematic review and meta-analysis.
     Front Pediatr. 2026;14:1836276.
     PubMed    
     Abstract available
     
     

120. WU Q, Zhou Z, Ye H, Zhang M, et al
     Belimumab as a possible treatment for SLE-associated pulmonary arterial hypertension: the experience from a single centre.
     Lupus Sci Med. 2026;13:e001960.
     PubMed    
     Abstract available
     
     

121. HENEMA MM, Smit FE, Brown SC, Botes L, et al
     Clinical and echocardiographic characteristics of patients presenting with pulmonary hypertension due to congenital heart disease.
     Cardiovasc J Afr. 2026;37:53-61.
     PubMed    
     Abstract available
     
     

122. HOSOKAWA K, Kohei M, Hirose M, Inami T, et al
     Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study.
     J Thromb Haemost. 2026 Jun 18:S1538-7836(26)00394.
     PubMed    
     Abstract available
     
     

123. SAPKOTA S, Sharma P, Fadah K, Usle Perez EI, et al
     Off-Label 16-mm VSD Occluder for Closure of a Giant PDA With Severe Pulmonary Hypertension.
     JACC Case Rep. 2026 Jun 18:108891. doi: 10.1016/j.jaccas.2026.108891.
     PubMed    
     Abstract available
     
     

124. R MURAD M, Awashra A, S Elgendy M, Kasem AW, et al
     Clinical, hemodynamic, and safety outcomes of sotatercept in pulmonary arterial hypertension: a meta-analysis of randomized trials with time-to-event data.
     Ther Adv Respir Dis. 2026;20:17534666261459209.
     PubMed    
     Abstract available
     
     

125. LEBBINK JS, Smits M, van der Hoeven BL, Scholzel BE, et al
     Dynamic left main coronary artery compression by a dilated pulmonary artery in a patient with pulmonary hypertension-a case report demonstrating the significance of multimodular imaging.
     Eur Heart J Case Rep. 2026;10:ytag295.
     PubMed    
     Abstract available
     
     

126. ABBAS KZ, Caton T, Rali P
     Long-term Complications of Pulmonary Embolism: Which Is the Optimal Follow-Up?
     Heart Fail Clin. 2026;22:387-397.
     PubMed    
     Abstract available
     
     

127. COHEN SP, Miller AL, Rajpal S, Visovatti SH, et al
     Recent Advances in Pulmonary Hypertension Management.
     Heart Fail Clin. 2026;22:371-385.
     PubMed    
     Abstract available
     
     

128. BISCHOF E, Haber C, Lidstromer N
     The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension.
     Heart Fail Clin. 2026;22:361-370.
     PubMed    
     Abstract available
     
     

129. JOHN T, Stauber RE, Douschan P
     Portopulmonary Hypertension: Current Perspectives.
     Heart Fail Clin. 2026;22:353-360.
     PubMed    
     Abstract available
     
     

130. NERINO S, Casella C, Capasso E, Marino F, et al
     Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.
     Heart Fail Clin. 2026;22:341-352.
     PubMed    
     Abstract available
     
     

131. MORAGON-LEDESMA S, Demelo-Rodriguez P, Galeano-Valle F
     Long-term Complications of Venous Thromboembolism: A Practical Guide.
     Heart Fail Clin. 2026;22:329-339.
     PubMed    
     Abstract available
     
     

132. MAVROMANOLI AC, Mavromanolis CA
     Advances in the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension.
     Heart Fail Clin. 2026;22:291-299.
     PubMed    
     Abstract available
     
     

133. NARDI E, Abbellito GM, Marzano F, Gargiulo P, et al
     Pulmonary Hypertension: From Molecular Pathways to Patient Care.
     Heart Fail Clin. 2026;22:261-272.
     PubMed    
     Abstract available
     
     

134. LISHINSKY-FISCHER N, Levy J
     PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort Analysis.
     Retina. 2026;46:1251-1257.
     PubMed    
     Abstract available
     
     

135. SMITH TM, Restaino K, Lipsitz S, Khurana JK, et al
     Extracorporeal Membrane Oxygenation in Pediatric Pulmonary Hypertension: A Single-Center Cohort to Inform Decision-Making.
     ASAIO J. 2026 Jun 22. doi: 10.1097/MAT.0000000000002766.
     PubMed    
     Abstract available
     
     

136. ALVES-JR JL, Amado VM, Correa RA, Campos FAFT, et al
     Diagnosis of pulmonary arterial hypertension: a statement from the Brazilian Thoracic Association.
     J Bras Pneumol. 2026;51:e20250065.
     PubMed    
     Abstract available
     
     

137. BAI Q, Liu H, Wang H, Yao Y, et al
     Clinical research on pulmonary hypertension from a 2025 perspective: a narrative review.
     J Thorac Dis. 2026;18:552.
     PubMed    
     Abstract available
     
     

138. 
     Correction to "Male Sex Is Associated With Severe Pulmonary Hypertension and Worse Outcome in Chronic Obstructive Pulmonary Disease Patients Referred for Right Heart Catheterization".
     Pulm Circ. 2026;16:e70338.
     PubMed    
     Abstract available
     
     

139. CHURCH C, Molina-Molina M, Arias-Guillen M, Muchmore P, et al
     A Phase 2 Study of the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease.
     Pulm Circ. 2026;16:e70322.
     PubMed    
     Abstract available
     
     

140. TUTTLE M, Tighiouart H, Oka T, McCallum W, et al
     The Association Between Pulmonary Hypertension, End-Stage Kidney Disease, and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC).
     Kidney Med. 2026;8:101399.
     PubMed    
     Abstract available
     
     

141. LES O, Aghabekyan T, Bhamidipati D, Belligund P, et al
     Use of anticoagulants as a supportive measure in pulmonary hypertension: a narrative review.
     Tuberc Respir Dis (Seoul). 2026 Jun 16. doi: 10.4046/trd.2026.0047.
     PubMed    
     Abstract available
     
     

142. TARRAS ES, Yan X, Gange C, Kurz S, et al
     Beyond PVR: dynamic physiologic assessment enhances prognostic evaluation in pulmonary hypertension associated with chronic obstructive pulmonary disease.
     BMJ Open Respir Res. 2026;13:e004192.
     PubMed    
     Abstract available
     
     

143. HAJIAHMADI S, Mirdamadi A, Tajmirriahi M, Fadavi S, et al
     Quantitative CT Pulmonary Angiography and Echo Cardiography Analysis for Enhanced Cardiovascular Assessment of Right Ventricular Failure in Pulmonary Hypertension.
     Int J Gen Med. 2026;19:612693.
     PubMed    
     Abstract available
     
     

144. JIANG Y, Liu Z, Su C, Chen Y, et al
     Prevalence and risk factors of echocardiographically suspected pulmonary hypertension in maintenance hemodialysis patients: a retrospective study.
     BMC Cardiovasc Disord. 2026 Jun 15. doi: 10.1186/s12872-026-06128.
     PubMed    
     Abstract available
     
     

145. BALTODANO DANGLA CR, Romero Rios CK, Urbina Malianos CJ, Canales Reyes MA, et al
     Arterial tortuosity syndrome presenting as severe precapillary pulmonary hypertension in adulthood.
     Int J Cardiol Congenit Heart Dis. 2026;25:100683.
     PubMed    
     Abstract available
     
     

146. HARDCASTLE SJ, Wells Z, Keen C, Condliffe R, et al
     Factors Influencing Physical Activity Engagement Amongst Those Living With Pulmonary Hypertension in the UK.
     Pulm Circ. 2026;16:e70332.
     PubMed    
     Abstract available
     
     

147. HAN Y, Zhang H, Zhang J
     Altered early-life gut microbiota in offspring of pregnancies complicated by CHD-associated pulmonary hypertension.
     Front Microbiomes. 2026;5:1785707.
     PubMed    
     Abstract available
     
     

148. VERA RICAURTE M, Kosak Lopez E, Geller A, Leguizamon R, et al
     Pulmonary vasodilator therapy in COPD-associated pulmonary hypertension: A real-world case series of 14 patients confirmed by right heart catheterization.
     Respir Med Case Rep. 2026;62:102443.
     PubMed    
     Abstract available
     
     

149. WING R, Erdbrupsilongger U, Miller E, Morsy M, et al
     Pulmonary Hypertension, the Forgotten Right Ventricle, and Vascular Access in Hemodialysis Patients.
     Clin J Am Soc Nephrol. 2026 Jun 12. doi: 10.2215/CJN.0000001147.
     PubMed    
     
     
     

150. KADOSH S, Baidats Y, Jones AM, Wilkerson D, et al
     Oxygen Supplementation Improves Oxygen Uptake Kinetics and Exercise Performance in PAH and CTEPH Patients.
     Compr Physiol. 2026;16:e70194.
     PubMed    
     Abstract available
     
     

151. WAMBACH JA, Cole FS, Nogee LM
     Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant.
     Clin Perinatol. 2026;53:381-401.
     PubMed    
     Abstract available
     
     

152. HUME P, Khanal L, Lakshminrusimha S, Sankaran D, et al
     Management of Hypoxemic Respiratory Failure in the Newborn During Therapeutic Hypothermia.
     Clin Perinatol. 2026;53:317-332.
     PubMed    
     Abstract available
     
     

153. YANG MJ, Douglass M, Carpenter RJ, Yoder BA, et al
     Respiratory Management for the Infant with Congenital Diaphragmatic Hernia.
     Clin Perinatol. 2026;53:277-295.
     PubMed    
     Abstract available
     
     

154. CHACON-ABRIL K, Portela-Hernandez M, Fajardo-Hermosillo LD, Limon-Camacho L, et al
     Guide from the Colegio Mexicano de Reumatologia for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.
     Reumatol Clin (Engl Ed). 2026;22:502164.
     PubMed    
     Abstract available
     
     

155. MULLAGURA HN, Gharahi H, Figueroa CA, Baek S, et al
     Baseline state for pulmonary vasculature with pulmonary arterial hypertension: effect of geometric remodeling and metabolic shift.
     Biomech Model Mechanobiol. 2026;25:68.
     PubMed    
     Abstract available
     
     

156. TIAN H, Liu Z, He J, Wei R, et al
     Integrative multi-omics and machine learning reveal glycolysis-related biomarkers driving vascular remodeling in pulmonary arterial hypertension.
     Mol Cell Biochem. 2026;481:2639-2654.
     PubMed    
     Abstract available
     
     

157. HOCH CR, Brewer B, Matura LA
     Presenting symptom patterns of pulmonary arterial hypertension across adult age groups and etiologies: Implications for early recognition.
     Heart Lung. 2026;78:102837.
     PubMed    
     Abstract available
     
     

158. ZHENG C, Huo Y, Zhang X, Wang F, et al
     xCT/SLC7A11-mTOR axis promotes vascular remodeling in pulmonary arterial hypertension.
     Int J Biochem Cell Biol. 2026;197-198:106969.
     PubMed    
     Abstract available
     
     

159. NEARY JM
     Review of Right Heart Failure.
     Vet Clin North Am Food Anim Pract. 2026;42:195-208.
     PubMed    
     Abstract available
     
     

160. LANGLEBEN D, Orfanos SE, Fox BD, Giovinazzo M, et al
     Decreased exercise-induced pulmonary capillary recruitment in pulmonary arterial hypertension.
     Vascul Pharmacol. 2026;163:107615.
     PubMed    
     Abstract available
     
     

161. WANG J, Guo J, Zhao J, He J, et al
     Characteristics and prognostic value of cardiovascular magnetic resonance imaging-derived left ventricular hemodynamics in pulmonary arterial hypertension.
     J Cardiovasc Magn Reson. 2026;28:102742.
     PubMed    
     Abstract available
     
     

162. VICENZI A, Pagnoni G, Coppi F
     Right ventricular-centered metabolomics: A promising tool for phenotyping pulmonary arterial hypertension.
     Clin Chim Acta. 2026;589:121025.
     PubMed    
     Abstract available
     
     

163. ZHANG Y, Shan L, Dai J, Zhou Z, et al
     Prognostic value of cardiopulmonary exercise testing in connective tissue disease-associated pulmonary arterial hypertension at low and intermediate-low risk.
     Clin Rheumatol. 2026;45:3543-3553.
     PubMed    
     Abstract available
     
     

164. VIRSINSKAITE R, Beattie CJ, Karia N, Kotecha T, et al
     Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a cardiovascular magnetic resonance study in intermediate-high risk pulmonary arterial hypertension.
     J Cardiovasc Magn Reson. 2026;28:102714.
     PubMed    
     Abstract available
     
     

165. TAN W, Hu Y, Hu L, Chen Z, et al
     Ferroptosis inhibitors: latest advances and therapeutic potential for pulmonary arterial hypertension.
     Drug Discov Today. 2026;31:104635.
     PubMed    
     Abstract available
     
     

166. FARMAKIS IT, Valerio L, Barco S, Hobohm L, et al
     Follow-up algorithm for detecting chronic sequelae of pulmonary embolism: diagnostic performance and possible limitations.
     J Thromb Haemost. 2026;24:2532-2543.
     PubMed    
     Abstract available
     
     

167. NIEDERER SA, Balmus M, Burr C, Chico TJA, et al
     Digital twins for cardiopulmonary medicine: the case for pulmonary arterial hypertension.
     Am J Respir Crit Care Med. 2026;212:1203-1213.
     PubMed    
     Abstract available
     
     

168. AGARWAL S, Bankar A, Heo L, Mitra A, et al
     CES1 deficiency is associated with metabolic reprograming and endothelial dysfunction in pulmonary arterial hypertension.
     Am J Respir Crit Care Med. 2026;212:1315-1329.
     PubMed    
     Abstract available
     
     

169. GARCIA AR, Vollmer I, Blanco I, San Jose Estepar R, et al
     Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease.
     Chest. 2026 May 27:S0012-3692(26)00704-X. doi: 10.1016/j.chest.2026.
     PubMed    
     Abstract available
     
     

170. TOSHNER M, Morris N
     Actigraphy in Pulmonary Hypertension Clinical Trials: Time to Step Up?
     Chest. 2026;169:1444-1446.
     PubMed    
     
     
     

171. LYON ZM, Kolaitis NA
     Is It Time to Focus Efforts to Better Understand Group 3 Pulmonary Hypertension in Patients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis?
     Chest. 2026;169:1432-1433.
     PubMed    
     
     
     

172. LU K, Barros LM, Murinova N, Buber J, et al
     Pulmonary Arterial Hypertension Associated With Calcitonin Gene-Related Peptide Antagonist Therapy for Migraine: A Case Series.
     Chest. 2026;169:e175-e179.
     PubMed    
     Abstract available
     
     

173. MINHAS J, Shou H, Al-Naamani N, Feng R, et al
     Daily Physical Activity in Pulmonary Arterial Hypertension: Insights From a Multicenter Longitudinal Trial Using Accelerometry.
     Chest. 2026;169:1660-1671.
     PubMed    
     Abstract available
     
     

174. MOSS ME, Klouda T, Li Y, Liu Y, et al
     Hypoxia Induces Adaptive Lymphangiogenesis via Cd74 and Vegfr3 to Modulate Pulmonary Hypertension.
     Circ Res. 2026 Jun 3. doi: 10.1161/CIRCRESAHA.126.326822.
     PubMed    
     Abstract available
     
     

175. YANG S, Wang Z, Yang T, Liu Y, et al
     Restoring TRPV4-KCa2.3 Coupling to Treat Pulmonary Arterial Hypertension.
     Circ Res. 2026;139:e326135.
     PubMed    
     Abstract available
     
     

176. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
     Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
     Circulation. 2026;153:e1362.
     PubMed    
     
     
     

177. HOU Y, Li Q, Wei TW, Lin X, et al
     Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.
     Circulation. 2026 May 26. doi: 10.1161/CIRCULATIONAHA.124.073606.
     PubMed    
     Abstract available
     
     

178. WANG Q, Tian J, Liu D, Zheng T, et al
     Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension.
     Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.066183.
     PubMed    
     Abstract available
     
     

179. GUY K, Isaiah A
     Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.
     Curr Opin Pulm Med. 2026 May 26. doi: 10.1097/MCP.0000000000001287.
     PubMed    
     Abstract available
     
     

180. LEUZZI FR, Clausen ES, Dilling DF
     The changing face of lung transplant candidates.
     Curr Opin Pulm Med. 2026;32:335-340.
     PubMed    
     Abstract available
     
     

181. BIRNHUBER A, Zeder K, Kwapiszewska G
     Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.
     Curr Opin Pulm Med. 2026 Jun 11. doi: 10.1097/MCP.0000000000001284.
     PubMed    
     Abstract available
     
     

182. SHAMS SM, Maldarelli ME, Yin Y, Cassady S, et al
     A clinical support tool using artificial intelligence to diagnose pulmonary hypertension.
     Eur Respir J. 2026 Jun 4:2600125. doi: 10.1183/13993003.00125-2026.
     PubMed    
     
     
     

183. APPENZELLER P, Toshner M
     Do risk scores in chronic thromboembolic pulmonary hypertension need to account for inflammation?
     Eur Respir J. 2026;67:2600283.
     PubMed    
     
     
     

184. GARRY JD, Ivy DD, Austin ED
     From case reports to a cohort: illuminating the spectrum of pulmonary hypertension in Noonan syndrome.
     Eur Respir J. 2026;67:2600064.
     PubMed    
     
     
     

185. GRYNBLAT J, Coulet F, Gagnadoux F, Montani D, et al
     Reply: FLNA loss-of-function variants in pulmonary hypertension: implications for genetic testing in congenital heart disease.
     Eur Respir J. 2026;67:2600770.
     PubMed    
     
     
     

186. MORA-GOMEZ M, Cruz-Utrilla A, Miranda-Alcaraz L, Gallego-Zazo N, et al
     Comment on: Pulmonary hypertension in patients carrying FLNA loss-of-function variants.
     Eur Respir J. 2026;67:2600577.
     PubMed    
     
     
     

187. KIM NH, Perez VJ, Kingrey J, David Hardy W, et al
     Methamphetamine-associated PAH on the rise in the US: geographic trends & disparities in patient demographics and treatment strategies.
     J Heart Lung Transplant. 2026;45:1123-1132.
     PubMed    
     Abstract available
     
     

188. GEUBE M, Abraham A, Kelava M, Bustamante SE, et al
     Cardiopulmonary Effects of Vasopressin Versus Norepinephrine in Cardiac Surgery Patients: a Single Cluster-Randomized Cross-over Trial.
     J Thorac Cardiovasc Surg. 2025 Nov 19:S0022-5223(25)00978.
     PubMed    
     Abstract available
     
     

189. YUAN Z, Chen J, Chen D, Xu G, et al
     Correction: Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats.
     PLoS One. 2026;21:e0350157.
     PubMed    
     Abstract available
     
     

190. YANG X, Zhou B, Yang Y, Dong Y, et al
     Integrative transcriptomic analysis identifies immune-associated candidate genes and altered immune cell infiltration in pulmonary arterial hypertension.
     PLoS One. 2026;21:e0350015.
     PubMed    
     Abstract available
     
     

191. PAN Q, Chen H, Pan H, Hu Z, et al
     Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.
     PLoS One. 2026;21:e0346792.
     PubMed    
     Abstract available
     
     

192. HOSOKAWA K, Yamasaki Y, Kishimoto J, Nagayama T, et al
     Facilitating early diagnosis of chronic thromboembolic pulmonary hypertension with dynamic chest radiography: Protocol for a multicenter, assessor-blinded, case-wise randomized superiority reader study (FIND-DCR).
     PLoS One. 2026;21:e0350858.
     PubMed    
     Abstract available
     
     

193. VILLARREAL ES, Marinho Y, Loya O, Aboagye SY, et al
     Endothelial c-IAP2 loss amplifies P2X7 receptor-driven inflammation and worsens schistosomiasis-associated pulmonary hypertension.
     Proc Natl Acad Sci U S A. 2026;123:e2513158123.
     PubMed    
     Abstract available